Mitochondrial Genetic Testing: What It Can and Cannot Tell You

Mitochondrial genetic testing looks for disease-causing variants in mitochondrial DNA or nuclear DNA genes that affect mitochondrial function. It is usually considered when symptoms, family history, or specialist evaluation suggest a mitochondrial disorder. Results can guide diagnosis, family counseling, and trial eligibility, but testing should be ordered and interpreted with genetics expertise.

What is mitochondrial genetic testing?

Mitochondrial genetic testing is testing that looks for genetic variants linked to primary mitochondrial disease. These variants can be in mitochondrial DNA, called mtDNA, or in nuclear DNA, called nDNA, because both genomes help build and run mitochondria 1.

Mitochondria are the small energy-making structures inside cells. They are especially important in high-energy tissues like the brain, heart, skeletal muscle, eyes, ears, digestive tract, and endocrine organs 2.

What mitochondrial DNA and nuclear DNA each do

Mitochondrial DNA is a small circular genome inside mitochondria. It contains genes needed for oxidative phosphorylation, the process cells use to turn nutrients into usable energy 1.

Nuclear DNA is the larger genome in the cell nucleus. Many proteins that mitochondria need are encoded by nuclear genes, so a mitochondrial disorder can come from either mtDNA or nDNA 1.

Why mitochondrial disorders can be hard to diagnose

Mitochondrial disorders can look different from person to person. One person may have seizures and stroke-like episodes, while another may have myopathy, cardiomyopathy, vision loss, hearing loss, or exercise intolerance 2.

Diagnosis is also hard because many common conditions can mimic mitochondrial disease. A careful exam, family history, labs, imaging, and sometimes tissue testing may be needed before or after genetic testing 3.

What a genetic test can confirm—and what it cannot prove

A genetic test can sometimes identify a pathogenic variant or likely pathogenic variant that explains a person’s symptoms. This can support a diagnosis, guide family testing, and help a specialist decide whether a person may qualify for disease-specific research or clinical trials 1.

A genetic test cannot prove that every symptom is caused by mitochondria. It also cannot prove that a wellness intervention extends human lifespan. In longevity research, changes in biomarkers are not the same as proof of longer life.

Quick facts about mitochondrial genetic testing

mtDNA testing and nuclear mitochondrial gene testing answer related but different questions. The right test depends on symptoms, age of onset, family history, and which tissue is most likely to show the variant.

• Mitochondrial disease can involve mtDNA or nDNA variants 1.
• mtDNA is usually inherited from the mother, while nDNA variants may come from either parent or arise de novo 1.
• Next-generation sequencing is often preferred over testing only a few common mtDNA variants because mitochondrial disorders are genetically diverse 1.
• If blood testing is negative but clinical suspicion remains high, another tissue may be considered because heteroplasmy can vary by tissue 1.
• Genetic counseling is strongly recommended when pursuing mitochondrial genetic testing 2.

Who should consider testing for mitochondrial disease?

Mitochondrial disease testing is usually considered when a person has symptoms, exam findings, lab findings, or family history that fit a possible mitochondrial disorder. Some medical policies consider testing medically necessary when signs and symptoms are present and testing may establish a genetic diagnosis or reduce the need for invasive testing such as muscle biopsy 1.

Symptoms that may raise suspicion

Suspicion may rise when symptoms involve several high-energy systems at once. Examples include seizures, stroke-like episodes, ataxia, neuropathy, muscle weakness, exercise intolerance, lactic acidosis, cardiomyopathy, vision loss, hearing loss, digestive problems, and endocrine issues such as diabetes 2.

Named mitochondrial syndromes include MELAS, MERRF, Leigh syndrome, Kearns-Sayre syndrome, chronic progressive external ophthalmoplegia, and Leber hereditary optic neuropathy. These labels describe clinical patterns, but genetics can still be complex 2.

Family history patterns that matter

A three-generation family history can help show the possible inheritance pattern. A pattern where affected women pass symptoms to children of any sex, but affected men do not pass the condition to their children, can suggest mtDNA inheritance 1.

Other patterns may suggest autosomal dominant, autosomal recessive, X-linked, or de novo nuclear DNA variants. This is one reason a genetic counselor or clinical geneticist is helpful before testing 1.

Why a clinical genetics or mitochondrial medicine specialist may be involved

Mitochondrial testing is not a single yes-or-no test. Specialists help choose between mitochondrial genome sequencing, a nuclear mitochondrial gene panel, whole exome sequencing, whole genome sequencing, targeted familial variant testing, and tissue-based testing 3.

What symptoms can mitochondrial disease cause?

Primary mitochondrial disease often affects organs that need a lot of energy. Symptoms can begin in childhood or adulthood, and severity can range from mild to life-threatening 3.

Brain and nervous system symptoms

Brain and nerve symptoms can include seizures, stroke-like episodes, ataxia, neuropathy, developmental delay, migraine-like episodes, and problems with balance or coordination. MELAS is one example where stroke-like episodes and lactic acidosis can occur 2.

Muscle symptoms and exercise intolerance

Muscle symptoms can include myopathy, weakness, fatigue with exertion, cramps, or exercise intolerance. Some people have chronic progressive external ophthalmoplegia, where eye muscles weaken over time 2.

Heart, vision, hearing, digestive, and endocrine symptoms

Mitochondrial disease may involve cardiomyopathy, heart rhythm problems, vision loss, hearing loss, constipation, poor gut motility, swallowing problems, diabetes, or other endocrine issues. These symptoms are not specific to mitochondrial disease, so testing is interpreted in the full clinical context 2.

Why symptoms vary widely between people

Symptoms vary because different genes, tissues, and levels of heteroplasmy can be involved. Heteroplasmy means a person has a mix of normal and altered mtDNA; homoplasmy means most or all mtDNA copies are the same 1.

Are mitochondria inherited from mom or dad?

Mitochondrial DNA is usually inherited from the mother, but mitochondrial disease is not always maternal. Nuclear DNA genes that affect mitochondria can be inherited from either parent or can arise as new, de novo variants 1.

Maternal inheritance of mitochondrial DNA

Most mtDNA is passed through the egg, so mtDNA conditions often follow a maternal pattern. A mother with a pathogenic mtDNA variant may pass it to children of any sex, while fathers generally do not pass mtDNA variants to their children 1.

Nuclear DNA inheritance from either parent

Nuclear mitochondrial genes sit in the chromosomes in the nucleus. Variants in these genes can follow autosomal recessive, autosomal dominant, or X-linked inheritance, depending on the gene and variant 1.

De novo variants and why family history can be unclear

A de novo variant is a new genetic change in the affected person. This can make family history look negative even when a true genetic mitochondrial disorder is present 1.

Heteroplasmy: why severity can differ within a family

Heteroplasmy can explain why relatives with the same mtDNA variant may have different symptoms. The percentage of altered mtDNA can differ between people and between tissues within the same person 1.

What types of mitochondrial genetic tests are used?

Mitochondrial genome sequencing is one common test, but it is not the only option. A specialist may choose mtDNA testing, nuclear gene testing, whole exome sequencing, whole genome sequencing, or tissue testing based on the person’s clinical picture 3.

Mitochondrial genome sequencing

For suspected mtDNA disease, next-generation sequencing or massively parallel sequencing of the mitochondrial genome is generally preferred over testing only a limited set of common point mutations 1.

Targeted variant testing when a family variant is known

If a pathogenic familial variant has already been found, targeted familial variant testing can be used for at-risk relatives. Some policies describe this as medically necessary for preconception carrier testing when a defined, clinically important familial mitochondrial disorder is present 1.

Nuclear mitochondrial gene panels

When nuclear gene causes are suspected, broad next-generation sequencing panels can be useful because similar symptoms may come from variants in different genes. This is why single-gene testing is often too narrow unless the clinical pattern clearly points to one gene 1.

Whole exome sequencing and whole genome sequencing

Whole exome sequencing and whole genome sequencing may be used when the diagnosis remains unclear. Real-world diagnostic pathways vary by health system and may combine mtDNA testing, nuclear gene panels, exome sequencing, genome sequencing, and specialist interpretation 4.

Tissue testing when blood testing is not enough

If blood testing is negative but suspicion for an mtDNA disorder remains strong, testing another tissue may be needed because heteroplasmy can vary by tissue 1. Muscle biopsy or liver biopsy may still be considered in select cases.

How accurate is mitochondrial DNA testing?

Mitochondrial DNA testing accuracy depends on the test method, tissue tested, variant type, and level of heteroplasmy. Next-generation sequencing has improved detection, but no test rules out every mitochondrial disorder 1.

Why next-generation sequencing is preferred for mtDNA

Older testing sometimes looked only for a small set of common mtDNA mutations. Because mitochondrial disease can be caused by many different mtDNA variants, broad mitochondrial genome sequencing is often more informative 1.

Why heteroplasmy can affect detection

Heteroplasmy can be low in blood but higher in muscle, liver, urine, or another tissue. That means a blood test can be negative even when a clinically relevant mtDNA variant exists elsewhere 1.

Why some variants are reported as uncertain

A variant of uncertain significance, or VUS, means the lab found a genetic change but does not have enough evidence to call it disease-causing or benign. VUS results should not be used alone to diagnose a person or test relatives as if the result were proven 3.

When muscle or liver biopsy may still be considered

Genetic testing can reduce the need for invasive testing in some cases, but it does not replace every biopsy. A mitochondrial medicine specialist may still consider muscle biopsy, liver biopsy, respiratory chain studies, or tissue DNA testing when symptoms remain unexplained 3.

How much does mitochondrial DNA testing cost?

Mitochondrial DNA testing cost varies by test type, lab, insurance coverage, prior authorization, and whether genetic counseling is included. Because costs change often, the most useful step is to ask the ordering clinic and lab for a written estimate before testing.

Why prices vary by test type, lab, insurance, and counseling needs

A targeted test for a known family variant is different from a broad nuclear mitochondrial gene panel or whole genome sequencing. The broader the test and the more complex the interpretation, the more important counseling and clear billing become.

When insurance may consider testing medically necessary

Some medical policies consider mitochondrial genetic testing medically necessary when signs and symptoms of a mitochondrial disorder are present and testing may establish a genetic diagnosis or reduce the need for invasive testing such as muscle biopsy 1.

Questions to ask before paying out of pocket

• Is this test being ordered for diagnosis, cascade testing, preconception carrier testing, or general wellness information?
• Will the lab test mtDNA, nDNA, or both?
• What sample type is being used: blood, saliva, urine, muscle, liver, or another tissue?
• What happens if the result is negative or uncertain?
• Will a genetic counselor review the result with me?

What happens after a positive, negative, or uncertain result?

Mitochondrial genetic test results need careful interpretation. A result can be positive, negative, or uncertain, and each path has different next steps for diagnosis, family planning, and follow-up.

Positive or likely pathogenic results

A pathogenic variant or likely pathogenic variant may confirm a genetic diagnosis when it fits the person’s symptoms. This can help guide specialist care, family counseling, reproductive planning, and possible research eligibility 1.

Negative results when symptoms remain unexplained

A negative result does not always rule out mitochondrial disease. The test may not cover the right gene, the variant may be hard to detect, or the tested tissue may not carry enough altered mtDNA to show up 1.

Variants of uncertain significance

A VUS is common in broad genetic testing. It may be reclassified later as more evidence becomes available, but it should not be treated as a confirmed diagnosis without supporting clinical and laboratory evidence 3.

Cascade testing for relatives

Cascade testing means testing relatives after a disease-causing familial variant is found. A cross-sectional study of mitochondrial disease care found that cascade testing can identify at-risk relatives, but real-world uptake and implementation vary 5.

Does Chia offer mitochondrial genetic testing?

Chia does not currently offer mitochondrial genetic testing, genetic counseling, or diagnosis of mitochondrial disease. We publish longevity education to help patients ask better questions, but suspected mitochondrial disease needs a genetics clinic, clinical geneticist, genetic counselor, or mitochondrial medicine specialist.

When to seek a genetics clinic or mitochondrial disease specialist

Seek specialist evaluation if you have symptoms across multiple energy-demanding organs, a family history suggestive of maternal inheritance, unexplained myopathy, seizures, stroke-like episodes, cardiomyopathy, vision loss, hearing loss, or persistent lactic acidosis. A specialist can decide whether mtDNA testing, nDNA testing, tissue testing, or another diagnostic path is appropriate 3.

How Chia’s longevity content separates wellness biomarkers from disease diagnosis

Longevity research often studies biomarkers such as metabolism, inflammation, cellular stress, or mitochondrial function. Those markers can be useful research tools, but they do not diagnose mitochondrial disease and do not prove that a treatment extends human lifespan.

At Chia, we keep that line clear: wellness education is not genetic counseling, and a biomarker is not a diagnosis. If your concern is a possible inherited mitochondrial disorder, the right next step is a qualified genetics evaluation.

Is mitochondrial genetic testing FDA-approved?

Mitochondrial genetic tests used in clinical care are often laboratory-developed tests performed by qualified laboratories. Many are performed in CLIA-certified labs, and FDA clearance or approval may not be required for clinical use under current U.S. laboratory testing frameworks 2.

FAQ

Keep reading

Longevity Research

What Is Mitochondrial Inheritance? A Plain-English Guide

Longevity Research

Mitochondrial DNA and Disease: What Patients Should Know

Longevity Research

Mitochondrial DNA vs Nuclear DNA: Key Differences, Inheritance, and Health Meaning